Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease

Thromb Res. 2017 Feb:150:41-43. doi: 10.1016/j.thromres.2016.12.008. Epub 2016 Dec 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Alcoholism / blood
  • Alcoholism / complications*
  • Anticoagulants / pharmacology*
  • Anticoagulants / therapeutic use
  • Dabigatran / pharmacology
  • Dabigatran / therapeutic use
  • Enoxaparin / pharmacology
  • Enoxaparin / therapeutic use
  • Female
  • Hemostasis / drug effects*
  • Humans
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / etiology*
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / blood
  • Non-alcoholic Fatty Liver Disease / complications*
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Thrombosis / etiology
  • Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Enoxaparin
  • Pyrazoles
  • Pyridones
  • apixaban
  • Dabigatran